Fresenius Medical Care AG (FMS)
22.17
+0.04
(+0.18%)
USD |
NYSE |
Oct 16, 16:00
22.29
+0.12
(+0.54%)
After-Hours: 20:00
Fresenius Medical Care Research and Development Expense (Quarterly) : 46.08M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.08M |
| March 31, 2026 | 44.82M |
| December 31, 2025 | 45.39M |
| September 30, 2025 | 44.11M |
| June 30, 2025 | 43.20M |
| March 31, 2025 | 45.76M |
| December 31, 2024 | 53.33M |
| September 30, 2024 | 43.99M |
| June 30, 2024 | 49.08M |
| March 31, 2024 | 51.88M |
| December 31, 2023 | 70.96M |
| September 30, 2023 | 57.70M |
| June 30, 2023 | 62.24M |
| March 31, 2023 | 59.83M |
| December 31, 2022 | 63.20M |
| September 30, 2022 | 61.93M |
| June 30, 2022 | 59.06M |
| March 31, 2022 | 55.72M |
| December 31, 2021 | 77.72M |
| September 30, 2021 | 61.73M |
| June 30, 2021 | 62.66M |
| March 31, 2021 | 58.59M |
| December 31, 2020 | 61.99M |
| September 30, 2020 | 52.47M |
| June 30, 2020 | 55.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 50.59M |
| December 31, 2019 | 54.25M |
| September 30, 2019 | 54.67M |
| June 30, 2019 | 46.09M |
| March 31, 2019 | 38.17M |
| December 31, 2018 | 43.36M |
| September 30, 2018 | 29.94M |
| June 30, 2018 | 44.86M |
| March 31, 2018 | 39.20M |
| December 31, 2017 | 42.39M |
| September 30, 2017 | 32.77M |
| June 30, 2017 | 38.62M |
| March 31, 2017 | 34.25M |
| December 31, 2016 | 42.05M |
| September 30, 2016 | 43.82M |
| June 30, 2016 | 39.23M |
| March 31, 2016 | 37.48M |
| December 31, 2015 | 39.56M |
| September 30, 2015 | 35.01M |
| June 30, 2015 | 34.61M |
| March 31, 2015 | 30.49M |
| December 31, 2014 | 28.71M |
| September 30, 2014 | 29.81M |
| June 30, 2014 | 31.13M |
| March 31, 2014 | 30.71M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median